Merck partners with Isomorphic Labs on AI drug design
Published 8 h ago1 sourceEvidence: Reported
Merck and Isomorphic Labs announced a research collaboration to discover small-molecule oncology drug candidates. Financial terms and specific targets are undisclosed, and the deal is early-stage with no clinical candidates yet. It signals continued pharma adoption of AI-driven drug discovery, though commercial impact is years away.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Entities
Published 8 h ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago8 sourcesEvidence: Reported
Published 1 d ago6 sourcesEvidence: Reported